#Japan #Tokyo #Women's Health #vaginal health #MyLacto

MyLacto: Empowering Women Through Vaginal Flora Testing

As women increasingly focus on their reproductive health, understanding vaginal flora has become essential. MyLacto, a new service launched by Meiji Co. and Wellnize, is set to transform how women monitor their vaginal health from the comfort of their homes.

What is MyLacto?

Starting September 1, 2026, MyLacto offers a user-friendly at-home testing service designed especially for women who are considering pregnancy. This innovative solution allows users to send samples of vaginal secretions to a lab for analysis of Lactobacillus, the beneficial bacteria crucial for a healthy vaginal environment. This service aligns with Meiji's commitment to transparency in health and wellness.

The product is priced at ¥12,980, including tax and shipping. MyLacto not only provides insight into the levels of Lactobacillus but also delivers a comprehensive report that includes lifestyle advice to enhance vaginal health.

Why is Vaginal Flora Important?

Vaginal flora is a complex community of bacteria, with Lactobacillus being identified as a significant good bacteria. In a healthy vaginal environment, this type of bacteria dominates, which plays a key role in protecting against infections and maintaining overall reproductive health. Disruptions in this flora can lead to various health issues, including infertility. This understanding is especially pertinent as many women face challenges related to fertility in modern society.

Traditionally, the focus on studying Lactobacillus has been limited primarily to infertility clinics. However, MyLacto aims to broaden awareness among women about the importance of their vaginal environment and how it's intertwined with uterine health. This service provides the opportunity to understand and maintain a proper vaginal ecosystem, which significantly impacts overall health and fertility.

Contributions to Women's Health

Research indicates that approximately 3.4 trillion yen in economic losses arise from women's health issues each year in Japan, highlighting the societal need for enhanced focus on female health. As social dynamics evolve, women’s participation in the workforce increases, thus requiring better health monitoring mechanisms like MyLacto. As such, this service is a proactive step towards tackling women's specific health challenges.

Notably, the background of MyLacto is supported by findings linking vaginal flora to various health outcomes, including pregnancy success rates. Studies reveal that women with a 90% or higher level of Lactobacillus in their uterine flora have about double the pregnancy rates compared to those with lower levels.

Expert Perspective

Dr. Osamu Tsutsumi, a leading expert in obstetrics and gynecology, emphasizes the vital role of Lactobacillus in maintaining a healthy vaginal environment. He underscores that the knowledge gained from MyLacto can empower women to take charge of their reproductive health, thus facilitating informed decisions regarding fertilization and conception.

A Vision for the Future

Through MyLacto, Meiji and Wellnize endeavor to create a stronger bond between women and their health. By making this testing service accessible and convenient, they aim to encourage individuals to become more proactive in their health management. Regularly assessing vaginal flora can lead to improved wellness practices and provide women with the knowledge needed to make informed health choices.

In addition to launching this service, Meiji continues to develop the